Stay updated on APX005M Combo in Metastatic Pancreatic Cancer Clinical Trial
Sign up to get notified when there's something new on the APX005M Combo in Metastatic Pancreatic Cancer Clinical Trial page.

Latest updates to the APX005M Combo in Metastatic Pancreatic Cancer Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedAdded site revision tag v3.4.2 and removed the previous government funding status notice (v3.4.1).SummaryDifference0.4%

- Check21 days agoChange Detected- Notice about a lapse in government funding with guidance that the NIH Clinical Center is open and where to check status (opm.gov). - Revision: v3.4.1 added, replacing v3.4.0.SummaryDifference0.4%

- Check28 days agoChange DetectedThe glossary toggle was added, and a new 'Last Update Submitted that Met QC Criteria' field was introduced. The page revision was updated to v3.4.0 with capitalization changes to 'No FEAR Act Data'.SummaryDifference0.2%

- Check42 days agoChange DetectedThe page shows a minor revision update from v3.3.3 to v3.3.4 with no substantive changes to the study details or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check64 days agoChange DetectedAdded a consolidated Locations section listing California, Massachusetts, New York, Pennsylvania, and Texas, and removed the HHS Vulnerability Disclosure link; page revision updated to v3.3.3.SummaryDifference0.5%

- Check85 days agoChange DetectedRevision updated from v3.3.1 to v3.3.2; no other content changes were observed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to APX005M Combo in Metastatic Pancreatic Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the APX005M Combo in Metastatic Pancreatic Cancer Clinical Trial page.